Benefit from real world insight into common problems faced by organizations across their clinical trials. This presentation provides ideas, tools and techniques to overcome these issues and reach submission faster.
In this webinar recording, we'll give you an overview of the end-to-end clinical trial process, highlighting common challenges, with tools and techniques to overcome these and reach submission quicker.
With impending regulatory changes, in this presentation Formedix provides insight into the conversion of legacy/on-going studies to CDISC submission format and best use of CDISC standards in new trials.
Mark Wheeldon's presentation at the iMedNet User Group 2015 focuses on the use of CDISC to deliver time and cost savings across an end-to-end trial.
At CDISC International Interchange 2014, Formedix CEO Mark Wheeldon delivered this short "CDISC: Standards from the Start" presentation before participating in a panel discussion.
Formedix CEO Mark Wheeldon delivered this in-depth Define-XML presentation at PhUSE 2014 in London. You'll learn about Define-XML's varied uses beyond dataset description.
Mark Wheeldon (Formedix) and Paula McHale (PAREXEL Informatics) discuss available tools and standards to reduce the time and cost of an end-to-end clinical trial, in this webinar recording.
Mark Wheeldon explores the many and varied uses of Define-XML in this presentation from the PharmaSUG Annual Conference 2014 in San Diego.
Based on a recent poll, 71 percent of CDISC users have implemented Define-XML. This white paper explores alternative uses of Define-XML, from study set-up to production of CDISC Study Data.
This infographic illustrates six of the most common challenges that CROs experience in the battle to win sponsor business.
